Health Catalyst: Q3 Earnings Insights

Shares of Health Catalyst HCAT rose 2.39% in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share rose 22.22% over the past year to ($0.21), which beat the estimate of ($0.27).

Revenue of $47,191,000 up by 19.70% from the same period last year, which beat the estimate of $44,590,000.

Guidance

Earnings guidance hasn't been issued by the company for now.

The upcoming fiscal year's revenue expected to be between $186,100,000 and $189,100,000.

Conference Call Details

Date: Nov 10, 2020

Time: 05:00 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/hb94z5mg

Technicals

52-week high: $41.26

Company's 52-week low was at $17.48

Price action over last quarter: Up 13.39%

Company Description

Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, which is the key revenue driver, includes data platform, analytics applications and support services. This generates revenues primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; and Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.